Related Experiment Videos
Treatment non-response in OCD: methodological issues and operational definitions
Stefano Pallanti1, Eric Hollander, Carol Bienstock
1Mount Sinai School of Medicine, New York, NY, USA. s.pallanti@agora.stm.it
The International Journal of Neuropsychopharmacology
|July 24, 2002
Summary
Many patients with obsessive-compulsive disorder (OCD) do not respond to selective serotonin reuptake inhibitors (SRIs). This study proposes a nosology to better define treatment non-response in OCD for future research.
Area of Science:
- Psychiatry and Behavioral Sciences
- Clinical Psychology
- Pharmacology
Background:
- Selective serotonin reuptake inhibitors (SRIs) show limited efficacy in treating obsessive-compulsive disorder (OCD), with 40-60% of patients experiencing unsatisfactory outcomes.
- Treatment non-response in OCD leads to significant social disability and poses challenges for research due to diagnostic ambiguities, potential subtypes, and high comorbidity.
- Current research on non-responders is limited by the absence of a standardized definition of non-response, hindering the development of cumulative data on homogeneous patient samples.
Purpose of the Study:
- To identify and clarify obstacles in defining stages of treatment response and levels of non-response in obsessive-compulsive disorder (OCD).
- To propose a systematic nosology for classifying non-response to treatment in OCD.
- To facilitate more accurate patient clustering and multi-site data collection for future OCD treatment research.
Main Methods:
- Comprehensive analysis of existing literature and clinical data related to treatment response and non-response in obsessive-compulsive disorder (OCD).
- Critical examination of diagnostic criteria, potential OCD subtypes, and comorbidity patterns affecting treatment outcomes.
- Development of an operational definition for non-response to guide future research and clinical classification.
Main Results:
- Identified significant challenges in defining and categorizing treatment non-response in OCD, including diagnostic heterogeneity and lack of standardized criteria.
- Proposed a systematic nosology to differentiate various levels and stages of non-response to pharmacological interventions in OCD.
- Highlighted the need for a unified definition to enable comparable research across different studies and patient populations.
Conclusions:
- A clear, operational definition and systematic nosology for treatment non-response are crucial for advancing research in obsessive-compulsive disorder (OCD).
- Improved characterization of treatment responders and non-responders will enable better patient stratification and facilitate robust multi-center research.
- The proposed nosology aims to enhance the understanding of treatment resistance in OCD, ultimately improving patient outcomes and therapeutic strategies.